Fibroepithelial lesions of the breast are commonly seen in clinical practice. The masses are composed of a combination of prominent stroma and varying glandular elements. Fibroadenomas, benign lesions that derive from the terminal duct lobular unit, are the most common and are often identified at clinical examination or mammography as circumscribed masses. Benign mesenchymal tumors include focal fibrosis, pseudoangiomatous stromal hyperplasia, and fibromatosis or desmoid tumor. Phyllodes tumor, which is similar to fibroadenoma but has increased cellularity in the stroma, is typically benign but has malignant potential. Diabetic fibrous mastopathy, a stromal proliferation found in patients with juvenile-onset insulin-dependent diabetes, is a reactive fibrous lesion. Most of these lesions manifest as masses at clinical and/or mammographic examination. Some (eg, fibroadenomas) may be associated with calcifications. Except for fibromatosis and phyllodes tumor, fibroepithelial lesions need not be excised if the diagnosis is confirmed by the results of histologic analysis at percutaneous biopsy. To correctly differentiate between fibrous breast lesions that are benign and those that should be resected, the physician must be familiar with the correlated radiologic-pathologic findings in the various lesion types.
Introduction
Fibrous breast lesions are commonly seen in clinical practice. These lesions are composed of prominent stromal elements and various amounts of glandular epithelium. The most common of these lesions is the fibroadenoma. Fibroadenomas most frequently occur as palpable masses in women of childbearing age, although 44% of fibroadenomas manifest in postmenopausal women (1) . A lesion that is similar to fibroadenoma both in its clinical manifestations and its imaging features is sclerosing lobular hyperplasia.
Benign mesenchymal breast tumors include those in focal fibrosis, pseudoangiomatous stromal hyperplasia, and fibromatosis, all of which are composed of dense stromal elements. In fibromatosis, fibroblasts and collagen form an infiltrative mass, known as extraabdominal desmoid tumor, that requires local excision with a wide margin.
Some fibrous breast lesions, such as phyllodes tumors, have malignant potential. Phyllodes tumors may be characterized according to pathologic findings as benign lesions or as low-grade (borderline) or high-grade malignancies. There are no clinical features that help to differentiate fibrous lesions with malignant potential from fibroadenomas. In addition, no mammographic or ultrasonographic (US) features aid differentiation between benign and malignant fibrous lesions (2).
In the presence of a very large and circumscribed breast mass, however, phyllodes tumor should rank high in the differential diagnosis.
Clinical history and physical examination can be very helpful for diagnosing some fibrous breast lesions. For example, in a type 1 diabetic who presents with a firm nontender mass in which a dense acoustic shadow is observed on US images, a diagnosis of diabetic fibrous mastopathy should be considered (2) . To better enable differentiation between fibrous breast lesions that are benign and those that should be resected, this article reviews the correlated radiologic and pathologic findings.
Fibroepithelial Lesions Fibroadenomas
Fibroadenomas are benign fibroepithelial tumors that develop in the lobules at the ends of mammary gland ducts, which are the basic units of analysis at histopathologic assessment. Fibroadenomas are composed of epithelium and stroma, and they are the breast tumors most commonly found in adolescent girls and young women at clinical examination and histopathologic analysis. When palpable, fibroadenomas are smooth, mobile and firm or rubbery. In 15% of cases, multiple fibroadenomas are present (1) . Fibroadenomas occasionally develop into very large masses, particularly in adolescent girls and young women; such masses are called juvenile giant fibroadenomas (Fig 1) .
At mammography, fibroadenomas appear as well-defined round, oval, or lobulated masses (Fig 2) . The masses may be calcified, with the most common pattern of calcification being initial small peripheral dots that coalesce over time into coarser popcorn-shaped features (Figs 3, 4) . In the presence of a calcified fibroadenoma, which is characteristically benign, further work-up, including US imaging or biopsy, is not needed. If a noncalcified isodense circumscribed mass is depicted at mammography, imaging with US is the next step toward characterization of the lesion. On US images, fibroadenoma appears as a well-circumscribed elliptic mass that is either hypoechoic or isoechoic and has uniform echogenicity. The lesion is typically larger in the transverse than in the anteroposterior direction and has very well-demarcated margins. A fibroadenoma may have no effect on ultrasound transmission, or acoustic enhancement or shadow may be observed on US images (Fig 5) .
Histopathologic features of fibroadenomas include the concurrent proliferation of stromal and glandular elements. Two histologic categories of fibroadenomas are described: intracanalicular and pericanalicular. In intracanalicular fibroadenomas, the stroma is dense and compresses the duct into a slitlike space. In pericanalicular lesions, there is no compression of the duct (2) (Fig 6) . Occasionally, small punctate, dystrophic, or pleomorphic calcifications may form in a fibroadenoma, and the mass may no longer be visible at mammography. In these cases, biopsy may be necessary because of the equivocal mammographic findings.
Special varieties of fibroadenoma include fibroadenoma with lactating adenoma, juvenile fibroadenoma, and tubular adenoma. A lactating adenoma occurs in the epithelium of a fibroadenoma during pregnancy. Tubular adenoma is a variant of pericanalicular fibroadenoma with a florid epithelium like that in adenosis (2) (Fig 7) . Juvenile fibroadenoma is characterized by prominent stromal cellularity and epithelial hyperplasia (2) (Fig 8) .
Phyllodes Tumors
Originally described in 1838 as cystosarcoma phyllodes (3) because of their leaflike pattern of growth, phyllodes tumors may be benign or malignant. The clinical manifestation is most often a firm or hard round tumor. Very large size or rapid growth may suggest a phyllodes tumor rather than a fibroadenoma. In patients who have very large phyllodes tumors, ulceration of the skin or invasion of the chest wall may occur.
On mammograms, a phyllodes tumor is a large well-circumscribed isodense mass that may include plaquelike calcifications. On US images, the tumor appears as a smooth and solid lobular mass, occasionally with cystic components (Figs  9, 10) .
Phyllodes tumors develop from the periductal stroma and contain sparse lobular elements. In comparison with fibroadenomas, phyllodes tu- mors are characterized by expansion and increased cellularity of the stroma. In addition, elongated epithelium-lined clefts are present (2) .
Benign phyllodes tumors are characterized by few if any mitoses, moderate to marked cellular overgrowth, and slight to moderate cellular pleomorphism (2). The tumors do not metastasize, but there is a 20% likelihood of local recurrence after excision (4). Low-grade malignant or borderline lesions include a zone of microscopic invasion around their borders, an average of two to five mitoses per 10 high-power field, and moderate stromal cellularity that is heterogeneously distributed in hypocellular areas (2) . Borderline lesions have a low (less than 5%) likelihood of metastasis and more than a 25% chance of local recurrence (4) . Malignant phyllodes tumors show a marked degree of hypercellular stromal overgrowth, with more than five mitoses per 10 highpower field, and have an invasive border (2) (Figs  11, 12 ). About 25% of phyllodes tumors metastasize (4). Treatment for malignant tumors is complete local excision with a broad surgical margin to lessen the likelihood of tumor recurrence. Mastectomy may be needed for very large lesions. Overall 5-year survival with phyllodes tumors is about 90% (5). However, in patients with highgrade phyllodes tumors, the 5-year survival is only 65% (6).
Other Benign Fibrous Lesions Sclerosing Lobular Hyperplasia
Sclerosing lobular hyperplasia, which is also known as fibroadenomatoid mastopathy, is a benign proliferative lesion that occurs most often in young black women. The most common clinical manifestation of this lesion is a circumscribed mass, which may be palpable. The mean age of patients at presentation is 32 years. On mammograms, the lesion resembles a noncalcified fibroadenoma (7) (Fig 13) . Pathologically, the lesion is characterized by enlarged lobules, an increased number of intralobular ductules (2) , and sclerosis of the intralobular septa.
Diabetic Fibrous Mastopathy
First described in 1984 (8), diabetic fibrous mastopathy is a form of stromal proliferation that is found in female patients with juvenile-onset insulin-dependent diabetes. The formation of these fibrous masses is thought to be related to an increased resistance of collagen to normal degradation. The lesions typically occur in young women, about 20 years after the onset of diabetes. Breast lesions of various kinds are found in about onehalf of all female patients with type 1 diabetes. Thyroiditis also is found in some women with juvenile-onset diabetes (9) .
The most common clinical manifestation of diabetic fibrous mastopathy is a firm to hard nontender breast mass. At mammography, generalized dense tissue is often present. The mass may appear as an asymmetry or an irregular lesion, or it may be obscured by dense tissue. Typically, US images show very dense and obvious acoustic shadows (10) . Multiple areas of acoustic shadow may be seen in either breast (Figs 14, 15) . At histopathologic examination, a collagenous stroma composed of an increased number of spindle cells and scattered epithelial cells is observed, with a lymphocytic infiltrate in the perivascular spaces. There is no associated increase in the risk of breast cancer or fibromatosis.
Focal Fibrosis (Fibrous Tumor)
Focal fibrosis, also known as fibrous mastopathy or fibrous disease, is similar to pseudoangiomatous stromal hyperplasia. Fibrous tumors typically occur in premenopausal women and manifest at clinical examination as a firm mass. At mammography, focal fibrosis may appear as a circumscribed or irregular mass (11) or as a focal asymmetric density. The mass is composed of dense collagenous stroma with sparse glandular and vascular elements (2) (Fig 16) .
Pseudoangiomatous Stromal Hyperplasia
Pseudoangiomatous stromal hyperplasia is a mesenchymal lesion that may be mistaken for angiosarcoma. The lesion is composed of myofibroblasts and sometimes includes glandular components. The most striking histologic finding is a complex pattern of empty anastomosing slitlike spaces within the stroma. Myofibroblasts may be present at the margins of these spaces (2) .
The condition typically occurs in premenopausal women but is frequently found incidentally at biopsy for gynecomastia (12) . Patients may manifest a firm but painless breast mass. Occurrence of the lesion during pregnancy may cause massive breast enlargement with skin necrosis. The most frequent mammographic manifestation is a clearly circumscribed mass, but indistinct margins and spiculation also have been noted (13) . US images may show a hypoechoic circumscribed mass that resembles a fibroadenoma (14) (Fig 17) .
Fibromatosis
Fibromatosis, also known as extraabdominal desmoid tumor, is a low-grade infiltrative spindle-cell tumor composed of fibroblasts and collagen. The mean age of patients at diagnosis is 37 years (15) .
Patients typically manifest a palpable firm or hard lump that is suspected of malignancy. The lesions tend to develop in the pectoralis fascia, in which they may be fixed and, thus, cause retraction of both the pectoralis muscle and the skin or nipple. Many patients report a history of minor trauma to the breast or prior breast surgery. There is some association between augmentation mammoplasty and the development of fibromatosis in the capsule around the breast implant (16) . On mammograms, fibromatosis appears as a round or irregular noncalcified mass, usually with indistinct margins or marginal spiculation (Fig 18) . At histopathologic analysis, spindle cells and collagen are present. The edges of the lesion show spiculation, evidence of extension into the surrounding breast tissue and fat. Glandular elements in the periphery of the mass may be engulfed. Mitotic activity is inconspicuous, a finding that helps to differentiate fibromatosis from fibrosarcoma (2) .
Fibromatosis is treated surgically with complete local excision, and it may recur locally if excision is incomplete. Fibromatosis recurs in approximately one-fourth of cases (15) .
Conclusions
The radiologic-pathologic correlation of findings in various fibrous lesions, their clinical manifestations, and their management have been discussed. Fibroepithelial lesions are encountered daily in a mammography practice and are most often benign. Fibroadenoma is the most common lesion in this group. Many of these lesions may mimic carcinoma either clinically or at mammography, but none are associated with an increased risk of lobular or intraductal breast cancer. Fibromatosis and phyllodes tumors require complete excision with a broad margin, or they may recur locally. Within this lesion category, the only malignancy is the malignant form of phyllodes tumor, which metastasizes in 25% of cases.
